TY  - JOUR
AU  - Gomez-Mauricio, Guadalupe
AU  - Moscoso, Isabel
AU  - Martin-Cancho, Maria-Fernanda
AU  - Crisostomo, Veronica
AU  - Prat-Vidal, Cristina
AU  - Baez-Diaz, Claudia
AU  - Sánchez-Margallo, Francisco Miguel
AU  - Bernad, Antonio
PY  - 2016
DO  - 10.1186/s13287-016-0350-z
SN  - 1757-6512
UR  - http://hdl.handle.net/20.500.12105/5210
AB  - Background: Insulin-like growth factor 1 (IGF-1) and hepatocyte growth factor (HGF) are among the most promising growth factors for promoting cardiorepair. Here, we evaluated the combination of cell-and gene-based therapy using mesenchymal stem cells...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Mesenchymal stem cells
KW  - HGF
KW  - IGF-1
KW  - Acute myocardial infarction
KW  - Porcine model
KW  - Gene therapy
KW  - Cell therapy
KW  - HEPATOCYTE GROWTH-FACTOR
KW  - ELEVATION MYOCARDIAL-INFARCTION
KW  - RANDOMIZED PHASE-1 TRIAL
KW  - PROGENITOR CELLS
KW  - INTRACORONARY INJECTION
KW  - HEART-FAILURE
KW  - IN-VITRO
KW  - REPAIR
KW  - THERAPY
KW  - ACTIVATION
TI  - Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model
TY  - journal article
ER  -